|
|
|
|
Therapeutic cancer vaccines show promise
It's a deceptively simple idea: What if doctors could recruit the body's own immune system to fight cancer?The complexities of the immune system have kept this from becoming reality, until now? Three cancer vaccines -- for prostate...
|
|
|
A brave boy's journey with cancer
Amit Katz, who's nine but insists he's about to turn 10, smiles infectiously as he sits in his Hod Hasharon home and recalls the fulfillment of a dream in Rome earlier this year.Amit, who was diagnosed with a form of cancer called 3B...
|
|
|
2009 Gruber Genetics Prize winner announced
Janet Rowley will receive the ninth annual prize, which recognizes groundbreaking work in genetics.The Peter and Patricia Gruber Foundation announced that Janet Davison Rowley of the University of Chicago (Chicago, IL) will be the 2009...
|
|
|
Vaccine cocktail might be more effective against certain cancers
Researchers are giving vaccines in combination with other drugs either to help boost the immune response or to attack the cancer on multiple fronts.Even if a vaccine produces an appropriate cancer-attacking immune response, it still may...
|
|
|
When Amit Katz met the great Kaka: A brave boy's journey with cancer
Amit Katz, who's nine but insists he's about to turn 10, smiles infectiously as he sits in his Hod Hasharon home and recalls the fulfillment of a dream in Rome earlier this year.Seasoned traveler: Amit Katz hangs on to his suitcase.
|
|
|
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease
Background.A 58-year-old man who had a 35-year history of Crohn's disease presented to our IBD center with a disease flare, pararectal fistulas and abscess formation. The patient had previously undergone ileocolic resection for a...
Nature Reviews Gastroenterology & Hepatology:
Jul 3 2009 11:37AM
Matching: lymphoma cell
|
Find similar documents
|
|
|
|
Flu Shot Doubles Cancer Risk In New Study
Getting a flu shot almost doubles the chance of getting cancer according to Lankes and colleagues.In a new study at the Feinberg School of Medicine of Northwestern University, Lankes found that a single flu shot at any time alters the...
|
|
|
Cancer geneticist Janet Davison Rowley to receive $500,000 Gruber genetics prize
- Janet Davison Rowley, MD, a founder in the field of cancer cytogenetics, will receive the 2009 Genetics Prize of The Peter and Patricia Gruber Foundation.She is being honored with the prestigious international award for discoveries of...
|
|
|
Patients with extensive limb disease have worse pcALCL prognosis
MedWire News: Patients with primary cutaneous anaplastic large cell lymphoma (pcALCL) and extensive limb disease (ELD) have a more aggressive disease course and a differential gene expression profile to other patients with the...
|
|
|
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease
_ Hepatosplenic T-cell lymphoma in a patient with Crohn's disease.
Nature Clinical Practice Gastroenterology & Hepato:
Jul 3 2009 10:08AM
Matching: lymphoma cell
|
Find similar documents
|
|
|
|
University of California - Los Angeles: UCLA cancer researchers develop model that may help identify cancer st
UCLA cancer researchers develop model that may help identify cancer stem cells Researchers at UCLA's Jonsson Comprehensive Cancer Center, on a quest to find lung cancer stem cells, have developed a unique model to allow further...
|
|
|
Stem Cell Possibilities Energize the Market
click to enlarge Estimated R&D expenditures Stem cells are the biological building blocks that form other cells in the body.Because of their universality and ability to replace or repair damaged tissue, the therapeutic...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cuta
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa., June 29 /PRNewswire/ -- Yaupon Therapeutics, a privately held specialty pharmaceutical company,...
|
|
|
Leukemia & Lymphoma Society Recognizes Aurora Physician as Man of the Year
MILWAUKEE, July 1 /PRNewswire/ -- Robert Taylor, M.D., was named Man of the Year by the Wisconsin Chapter of the Leukemia & Lymphoma Society.He received the honor at an awards ceremony Friday, June 26, at the Milwaukee...
|
|
|
NHL Less Deadly in Modern HIV Treatment Era
Two-thirds of HIV-positive individuals with non-Hodgkins lymphoma are alive a year after its diagnosis, European investigators report in a study published in the online edition of AIDS.A low nadir CD4 cell count was associated...
|
|
|
$500,000 Gruber Genetics Prize Awarded To Cancer Geneticist Janet Davison Rowley
Janet Davison Rowley, MD, a founder in the field of cancer cytogenetics and a renowned leader in molecular oncology, will receive the 2009 Genetics Prize of The Peter and Patricia Gruber Foundation.She is being honored with the...
|
|
|
Janet Rowley awarded Gruber Genetics Prize for cancer research
Janet Rowley, a founder in the field of cancer cytogenetics and a leader in molecular oncology, will receive the 2009 Genetics Prize of The Peter and Patricia Gruber Foundation for her research on recurrent chromosomal abnormalities in...
|
|
|
In ball of clay, cancer survivors find solace
People with life-threatening illnesses can feel as if they're spending all their time riding on a spherical track - fueled by anxiety and worry - in a car that just won't quit.'When you're going through something like this, you don't...
|
|
|
In ball of clay, cancer survivors find solace
People with life-threatening illnesses can feel as if they're spending all their time riding on a spherical track - fueled by anxiety and worry - in a car that just won't quit.'When you're going through something like this, you don't...
|
|
|
Patients with certain blood cancers eligible for Quick Disability Determination
Patients diagnosed with certain blood cancers are now eligible for the Social Security Quick Disability Determination process, ensuring a decision on their cases within just six to eight days.The Compassionate Allowance Initiative...
|
|
|
2. Personalized Anti-Cancer Vaccine, BiovaxID[R], Targeting B-cell Lymphomas
Biovest and idis Partner to Facilitate Patient Access to Lymphoma Vaccine Phase III Study Results to Be Presented at 'Best of ASCO' in Paris TAMPA, Fla.-- Biovest International, Inc. (Other OTC:BVTI), a majority-owned subsidiary...
|
|
|
Yaupon Completes Patient Enrollment For Phase-II Study Of Clearazide
Clearazide, for the treatment of Cutaneous T-cell Lymphoma Yaupon has completed enrollment for a pivotal phase-II clinical trial for Clearazide, for the treatment of early-stage cutaneous T-cell lymphoma (CTCL -...
|
|
|
Bio-Matrix Scientific Group Targets Hospitals Needing Cord Blood Storage
Bio-Matrix Scientific Group, Inc.(OTCBB:BMSN), a San Diego-based biotechnology company, announced today the launch of a national marketing program aimed at hospitals in need of storing umbilical cord blood specimens for future...
|
|
|
A story of cancer, canines and collaboration
RALEIGH, N.C.-With focus on the proverbial man's best friend, researchers from the and its neighbor, the , are combining their expertise to pinpoint the cause of non-Hodgkin lymphoma in humans and canines.The animal and human docs...
|
|
|
Can Spectrum Pharmaceuticals Benefit from FDA Action on Zevalin?
According to the American Cancer Society [ACS], non-Hodgkin lymphoma [also known as non-Hodgkins lymphoma, NHL, or sometimes just lymphoma] is a cancer that starts in cells of the lymph system, which is part of the...
|
